Abstract
OBJECTIVE
Although basal cell carcinoma (BCC) is prevalent in the older population, it can be rarely seen in younger people. This study aims to investigate the risk factors and characteristics of BCC in young patients.
METHODS
Pathology reports in a single tertiary care institution between 2010 and 2020 were retrospectively reviewed. Patients under the age of 35 who were diagnosed with BCC were included for the analysis. Data were gathered from medical records and pathology reports. Demographic characteristics, accompanying pathologies, and clinical findings of these patients were analyzed.
RESULTS
There were a total of 32 patients in our cohort. Out of 32 patients, 20 were female and 12 were male. One male patient and five female patients were younger than 18. An accompanying risk factor (Gorlin syndrome, XP, renal transplantation, etc.) was present in six patients. There were no known additional diseases or risk factors in 26 patients. Metastasis and recurrence were not reported in any of our patients. Contrary to the information in the literature, the patients with BCC at a young age were not found more aggressive in our study.
CONCLUSION
Contrary to the information in the literature, the patients with BCC at a young age were not found more aggressive in our study. Understanding the risk factors associated with BCC is essential for designing prevention strategies and favoring early diagnosis. Awareness of early-onset BCC aids in early diagnosis and treatment of the disease. Therefore, BCC should be in the differential diagnosis of skin lesions in the young population. In addition, when we encounter early-onset BCC, we should not forget the accompanying risk factors and syndromes.
Keywords: Basal cell carcinoma, early-onset, young patients
Highlight key points
Since BCC is not very rare in the young population, BCC should be in the differential diagnosis of skin lesions in the young population.
Contrary to what is known, early onset BCC may not be more aggressive.
Risk factors and BCC-related syndromes should be kept in mind when encountered with early-onset BCC.
Basal cell carcinoma (BCC) is a carcinoma derived from basal cells of the interfollicular epidermis and/or hair follicle. BCC’s exhibit morphological variation, but they invariably contain islands or nests of peripherally palisaded basaloid cells with hyperchromatic nuclei and scant cytoplasm [1, 2].
BCC is the most common malignancy in humans. Incidence rates are inversely related to geographical latitude and higher in the light-skinned population. The risk of BCC steadily increases by age and sun exposure. In the last classification of WHO, skin tumors report that 64% of BCCs are seen in the head and neck 24% and are seen in the trunk in adults [1].
However, the incidence of BCC is more common in the elderly it is strikingly increasing in younger age groups, particularly among women [3]. It is reported in the literature that there may be various risk factors in the formation of early-onset BCC. Exposure to indoor tanning and sun exposure is shown as the main responsible for risk factors [4]. Early-onset BCC has been associated with various syndromes and diseases in the literature. Childhood-onset of BCC has previously been associated with albinism, Bazex syndrome, basal cell nevus syndrome, nevus sebaceous, solid organ transplants, xeroderma pigmentosum, and radiotherapy-treated cancer [2, 5].
BCCs, except for some rare subtypes, have a good prognosis and do not show metastasis or recurrence. In the WHO classification of skin tumors, BCC subtypes are classified as high risk (basosquamous, sclerosing, infiltrating, sarcomatoid differentiation, and micronodular) and low risk (nodular, superficial, pigmented, infundibulocystic, and fibroepithelial) BCC subtypes [1]. This study aims to investigate the risk factors and characteristics of BCC in young patients.
MATERIALS AND METHODS
After obtaining the approval of the local ethics committee of SBU Konya Training and Research Hospital TUEK (date: 02/07/2020, decision no: 40/10). Pathology reports in a single tertiary care institution between 2010 and 2020 were retrospectively reviewed. All patients who were diagnosed with BCC were detected. Demographic data were gathered from medical records and pathology reports. Patients under the age of 35 who were diagnosed with BCC were examined in detail. Age, sex, comorbidities, risk factors for BCC, and pathological characteristics were analyzed patients under thirty-five. Pathology reports and slides were reviewed. Representative pictures were included in the study. The study was conducted in compliance with the principles included the Declaration of Helsinki.
Statistical Analysis
Statistical analysis of all data was performed using SPSS (Statistical Packages for the Social Sciences, software, edition 21, SPSS Inc. Chicago, USA).
RESULTS
A total of 1717 patients were diagnosed with BCC at our hospital between 2010 and 2020. The mean age was 70.6±13.8 (Table 1). Out of 1717, 32 patients (1.86%) were under the age of 35 at the time of diagnosis. Twenty patients were female and 12 were male. The mean age was 26.3±9.4 (range 6–35). One of the male patients (age 14) and 5 of the female patients (range 6–12) were younger than 18 (Table 1).
Table 1.
Total number | Age at first diagnosis, y Mean±SD | |
---|---|---|
All patients with BCC | 1717 | 70.6±13.8 |
Female | 859 | 70±14.2 |
Male | 858 | 76.5±13.3 |
Patients under <35 with BCC | 32 | 26.3±9.4 |
Female | 19 | 24.6±10.3 |
Male | 13 | 28.5±7.5 |
Patients under <18 with BCC | 6 | 10.8±2.4 |
Female | 5 | 10.2±2.2 |
Male | 1 | 14±0 |
BCC: Basal cell carcinoma.
Patients were equally distributed between the first and second half of the study period. No significant increase in the diagnosis of BCC in the younger population was noted in recent ten years. The histological subtypes were nodular (29 patients), superficial spreading (two patients), and pigmented BCC (1 patient). Low-risk subtypes were observed in all of our cases and none of our patients had high-risk subtypes (Table 2).
Table 2.
Histological subtypes | |
---|---|
Nodular | 29/32 |
Superficial-spreading | 2/32 |
Pigmented | 1/32 |
Tumor site | |
Head and neck | 31/32 |
Upper limb | 1/32 |
Trunk-lower limb | 0 |
Tumor focality | |
Unifocal | 29/32 |
Multifocal | 3/32 |
BCC: Basal cell carcinoma.
The location of BCC was head in all of our patients, except one patient had BCC in the upper extremity. Three patients (percentage 9%) had multifocal lesions, while others had a single lesion. One of the patients with multifocal lesions had a history of xeroderma pigmentosum. The other two patients also demonstrated BCC lesions on the face but they had no risk factors.
An accompanying risk factor was present in six patients (18%). The risk factors were Gorlin-Goltz syndrome, renal transplant history, Sebaceous nevus, Xeroderma pigmentosum, Epidermolysis bullosa, and extended sun exposure (living in Africa for 9 years) (Table 3). Additional comorbidities were detected in the other seven patients (Table 4). There were no known additional diseases or risk factors in the remaining 18 patients 56.2% (18/32). Metastasis and recurrence were not reported in any of our patients. None of our patients have artificial ultraviolet (UV) radiation, UV beds, or an indoor tanning history.
Table 3.
Risk factors | Age | Gender | Localization | Histological subtype |
---|---|---|---|---|
Gorlin-Goltz syndrome | 30 | M | Scalp midline | Superficial |
Renal transplant history | 30 | M | Left malar region | Nodular |
BCC developing from Sebaceous nevus | 21 | M | Scalp | Nodular |
Xeroderma pigmentosum | 17 | F | Forehead, cheek, infraorbital area, and left intranasal area (multiple lesions) | Nodular |
Epidermolysis bullosa | 6 | F | ? | Nodular |
Personal history of living in Africa for nine years | 25 | M | Medial left orbit | Nodular |
BCC: Basal cell carcinoma.
Table 4.
Comorbidity | Age | Gender | Localization | Histological subtype |
---|---|---|---|---|
Polycystic ovary syndrome | 25 | F | Scalp | Nodular |
Breast fibroadenoma | 26 | F | Nasal lateral | Nodular |
Antipsychotic drug use | 30 | M | Scalp | Nodular |
Irritable bowel disease | 32 | M | Arm | Superficial |
Diabetes mellitus (type II) | 35 | M | Two lesions Nasolabial region, medial of eye | Nodular |
Polymorphous light eruption | 32 | F | Right cantal region | Nodular Nodular |
Xerosis cutis | 21 | F | Frontal region |
DISCUSSION
There are various case reports and reviews in the literature regarding early-onset BCCs, and a few single-center case series have been reported [3, 5–18]. This study represents one of the biggest series of BCC in young patients in a single tertiary institution.
In our series, BCC cases under the age of 35 constitute 1.8% of all BCC cases, while this rate was found to be 2.5% in another study with a similar number of samples in Spain [10]. This result shows us that even if the incidence of BCC increases at a young age, it still constitutes a small part of all BCC cases. The low incidence of BCC in young patients could cause diagnostic delays due to a low index of suspicion. When we look at the gender distribution of our patients in all patients with BCC, interestingly, we see that there are equal numbers of male and female patients. In our patients under 35 and under 18, the female to male ratio was 1.46 (19/13) and 5 (5/1), respectively. It is striking that the average age of all age groups and our patients under 35 years old is slightly higher in men compared to women.
We know that BCC is primarily seen in the sun-exposed areas. As in other studies in the literature, the location of the head and neck stands out in our early-onset BCC cases [5, 10, 17]. Childhood-onset of BCC has previously been associated with albinism, Bazex syndrome, BCC nevus syndrome, nevus sebaceous, solid organ transplants, xeroderma pigmentosum, and radiotherapy-treated cancer [4, 12, 19, 20]. Similarly, some of these risk factors (Gorlin, XP, renal transplant, etc.) were present in six out of 32 patients. Interestingly, xerosis cutis and the polymorphic light eruption, which are the skin diseases, also, were not previously shown to be associated with BCC.
When we look at pediatric patients (0–18), there were known risk factors in two patients, while no known risk factors were found in four patients. Pathogenesis in children without risk factors is not fully known, and specific genetic and iatrogenic factors have not been defined yet. These patients may have mosaic genetic conditions [21].
In the literature, BCC in young patients independent of a syndrome or risk factor (idiopathic BCC) is thought to be more aggressive [9, 11, 12]. We found that 82% of our cases had idiopathic BCC. However, our results do not support this information. In our series, all subtypes were low-risk histological subtypes (Fig. 1, 2). Recurrence and aggressive subtypes were not observed in any of the cases with BCC at an early age in our series. The limitation of our study is that we could not add any molecular analysis for early-onset BCC.
Conclusion
Contrary to the information in the literature, the patients with BCC at a young age were not found more aggressive in our study. Understanding the risk factors associated with BCC is essential for designing prevention strategies and favoring early diagnosis. Awareness of early-onset BCC aids in early diagnosis and treatment of the disease. Therefore, BCC should be in the differential diagnosis of skin lesions in the young population. Furthermore, when we encounter early-onset BCC, we should not forget the accompanying risk factors and syndromes.
Footnotes
Cite this article as: Ugur Kilinc AN, Bayramoglu Z, Unlu Y. Early-onset basal cell carcinoma; wide case series at a single tertiary center in middle Anatolia. North Clin Istanb 2022;9(3):261–265.
Ethics Committee Approval
The Konya Training and Research Hospital Clinical Research Ethics Committee granted approval for this study (date: 02/07/2020, number: 40/10).
Conflict of Interest
No conflict of interest was declared by the authors.
Financial Disclosure
The authors declared that this study has received no financial support.
Authorship Contributions
Concept – ANUK; Design – ANUK; Supervision – YU, ZB; Materials – ANUK; Data collection and/or processing – YU; Analysis and/or interpretation – ANUK; Literature review – ANUK; Writing – ANUK, YU; Critical review – ZB.
References
- 1.Messina J, Epstein EHJ, Kossard S, Mc Kenzie C, Patel RM, Patterson JW, et al. Basal cell carcinoma. In: Elder DE, Massi D, Scolyer RA, Willemze R, editors. WHO Classification of Skin Tumours. 4th ed. Lyon, France: IARC Press; 2018. pp. 26–34. [Google Scholar]
- 2.McKee PH, Calonje E, Lazar A, Brenn T. Basal cell carcinoma. In: Calonje JE, Brenn T, Lazar AJ, Billings S, editors. McKee’s Pathology of the Skin: With Clinical Correlations. 5th ed. Elsevier Saunders; 2020. pp. 1170–1. [Google Scholar]
- 3.Christenson LJ, Borrowman TA, Vachon CM, Tollefson MM, Otley CC, Weaver AL, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005;294:681–90. doi: 10.1001/jama.294.6.681. [DOI] [PubMed] [Google Scholar]
- 4.Ferrucci LM, Cartmel B, Molinaro AM, Leffell DJ, Bale AE, Mayne ST. Indoor tanning and risk of early-onset basal cell carcinoma. J Am Acad Dermatol. 2012;67:552–62. doi: 10.1016/j.jaad.2011.11.940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Griffin JR, Cohen PR, Tschen JA, Mullans EA, Schulze KE, Martinelli PT, et al. Basal cell carcinoma in childhood: case report and literature review. J Am Acad Dermatol. 2007;57:S97–102. doi: 10.1016/j.jaad.2006.09.032. [DOI] [PubMed] [Google Scholar]
- 6.Sangen Y, Maeda A, Yudate T, Aragane Y, Kawada A, Tezuka T. Three cases of sporadic basal cell carcinoma occurred in young adults. Hifu no Kagaku. 2002;1:24–8. [Google Scholar]
- 7.Murray JE, Bradford C. Basal-cell cancer in children and young adults. N Engl J Med. 1960;262:440–3. doi: 10.1056/NEJM196003032620904. [DOI] [PubMed] [Google Scholar]
- 8.Cox NH. Basal cell carcinoma in young adults. Br J Dermatol. 1992;127:26–9. doi: 10.1111/j.1365-2133.1992.tb14820.x. [DOI] [PubMed] [Google Scholar]
- 9.Alcalay J, Ben-Amitai D, Alkalay R. Idiopathic basal cell carcinoma in children. J Drugs Dermatol. 2008;7:479–81. [PubMed] [Google Scholar]
- 10.Garcias-Ladaria J, Morales-Morato FJ, Cuadrado Rosón M, Rocamora V. Basal cell carcinoma in young adults. Actas Dermosifiliogr. 2017;108:376–7. doi: 10.1016/j.ad.2016.10.012. [DOI] [PubMed] [Google Scholar]
- 11.Leffell DJ, Headington JT, Wong DS, Swanson NA. Aggressive-growth basal cell carcinoma in young adults. Arch Dermatol. 1991;127:1663–7. [PubMed] [Google Scholar]
- 12.Grampurohit VU, Dinesh US, Rao R. Multiple cutaneous malignancies in a patient of xeroderma pigmentosum. J Cancer Res Ther. 2011;7:205–7. doi: 10.4103/0973-1482.82932. [DOI] [PubMed] [Google Scholar]
- 13.Efron PA, Chen MK, Glavin FL, Kays DW, Beierle EA. Pediatric basal cell carcinoma: case reports and literature review. J Pediatr Surg. 2008;43:2277–80. doi: 10.1016/j.jpedsurg.2008.08.035. [DOI] [PubMed] [Google Scholar]
- 14.Zoccali G, Pajand R, Giuliani M. Basal cell carcinoma in childhood: a case report. Pediatr Dermatol. 2013;30:144–5. doi: 10.1111/j.1525-1470.2011.01591.x. [DOI] [PubMed] [Google Scholar]
- 15.Milroy CJ, Horlock N, Wilson GD, Sanders R. Aggressive basal cell carcinoma in young patients: fact or fiction? Br J Plast Surg. 2000;53:393–6. doi: 10.1054/bjps.1999.3267. [DOI] [PubMed] [Google Scholar]
- 16.Almeida AC, Yamashita T, Conte B, Mattos AC, Veríssimo RP, Ferreira MC. Frequency of basal cell carcinoma in a population younger than 50 years of age: clinical study and literature review. An Bras Dermatol. 2009;84:692–4. doi: 10.1590/s0365-05962009000600021. [DOI] [PubMed] [Google Scholar]
- 17.LeSueur BW, Silvis NG, Hansen RC. Basal cell carcinoma in children: report of 3 cases. Arch Dermatol. 2000;136:370–2. doi: 10.1001/archderm.136.3.370. [DOI] [PubMed] [Google Scholar]
- 18.Deady S, Sharp L, Comber H. Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention. Br J Dermatol. 2014;171:324–31. doi: 10.1111/bjd.12988. [DOI] [PubMed] [Google Scholar]
- 19.Barton DT, Zens MS, Nelson HH, Christensen BC, Storm CA, Perry AE, et al. Distinct histologic subtypes and risk factors for early onset basal cell carcinoma: a population-based case control study from New Hampshire. J Invest Dermatol. 2016;136:533–5. doi: 10.1016/j.jid.2015.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Fine JD, Johnson LB, Weiner M, Li KP, Suchindran C. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006. J Am Acad Dermatol. 2009;60:203–11. doi: 10.1016/j.jaad.2008.09.035. [DOI] [PubMed] [Google Scholar]
- 21.Reinders MGHC, Boersma HJ, Leter EM, Vreeburg M, Paulussen ADC, Arits AHMM, et al. Postzygotic mosaicism in basal cell naevus syndrome. Br J Dermatol. 2017;177:249–52. doi: 10.1111/bjd.15082. [DOI] [PubMed] [Google Scholar]